Manchester University Nhs Foundation Trust
Clinical trials sponsored by Manchester University Nhs Foundation Trust, explained in plain language.
-
Could a Copper-Binding drug shrink an overgrown heart?
Disease control CompletedThis study tested whether a drug called trientine can reduce heart muscle thickening and improve exercise ability in people with hypertrophic cardiomyopathy, a condition where the heart muscle becomes abnormally thick. 154 adults took either trientine or a placebo for 12 months. …
Phase: PHASE2 • Sponsor: Manchester University NHS Foundation Trust • Aim: Disease control
Last updated Jun 08, 2026 13:06 UTC
-
Tiny shocks may beat big boots in preventing deadly clots
Prevention CompletedThis study tested whether a small, wearable device that sends mild electrical pulses to the leg muscles can prevent dangerous blood clots in critically ill adults. Forty ICU patients were randomly assigned to receive either the electrical device or standard compression boots. The…
Phase: NA • Sponsor: Manchester University NHS Foundation Trust • Aim: Prevention
Last updated Jun 16, 2026 12:54 UTC
-
Can a protein fluid help septic shock patients? small study tests the waters
Knowledge-focused CompletedThis study looked at whether giving a concentrated protein fluid called albumin, along with standard fluids, is possible in patients with septic shock (a life-threatening infection causing very low blood pressure). 47 adults took part to see if doctors could recruit enough patien…
Phase: PHASE2, PHASE3 • Sponsor: Manchester University NHS Foundation Trust • Aim: Knowledge-focused
Last updated Jun 09, 2026 12:07 UTC